PolyMedix Reports Second Quarter 2012 Financial Results

PolyMedix Reports Second Quarter 2012 Financial Results

Filed under: drug treatment news 2012

9, 2012 (GLOBE NEWSWIRE) — PolyMedix, Inc. (OTCBB:PYMX), a biotechnology company focused on developing innovative therapeutic drugs to treat patients with serious acute-care conditions, today announced its financial results for the second quarter …
Read more on Equities.com

Heroin Hair Treatment Products Make Their JFK Debut

Filed under: drug treatment news 2012

Another day, another interesting place that drug smugglers find to hide their wares. On Monday … Hair treatment products. Not as amusing as clams, but still! According to CBP on July 25, agents noticed that Cardona was bringing a whole lot of hair …
Read more on Gothamist

Shire CEO Sees New Uses for Attention-Deficit Drug Raising Sales

Filed under: drug treatment news 2012

Vyvanse, which was introduced in the U.S. in 2007, is currently approved to treat attention-deficit/hyperactivity disorder in children and adults. First-half 2012 sales were $ 526 million, or 22% of total company revenue, putting sales on pace to exceed …
Read more on Fox Business

Treating drug resistant cancer through targeted inhibition of sphingosine kinase

Filed under: drug treatment news 2012

New treatments specifically attacking cancer cells, but not normal ones, are critical in the fight against cancer. The results, which appear in the July 2012 issue of Experimental Biology and Medicine, demonstrate the role of SK in drug resistance and …
Read more on Science Codex

PolyMedix Reports Second Quarter 2012 Financial Results
RADNOR, Pa. — PolyMedix, Inc. , a biotechnology company focused on developing innovative therapeutic drugs to treat patients with serious acute-care conditions, today announced its financial results for … Read News